In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: a prespecified analysis of the VIP-ACS trial (2024)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2023.12.074
- Subjects: VACINAÇÃO; SÍNDROME CORONARIANA AGUDA; MORTALIDADE; INFLUENZA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
FONSECA, Henrique Andrade R et al. In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: a prespecified analysis of the VIP-ACS trial. Vaccine, v. 42, n. 3, p. 496-504, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58827. Acesso em: 17 mar. 2026. -
APA
Fonseca, H. A. R., Zimerman, A., Monfardini, F., Guimaraes, H. P., Pedrosa, R. P., Patriota, R. de L. S., et al. (2024). In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: a prespecified analysis of the VIP-ACS trial. Vaccine, 42( 3), 496-504. doi:10.1016/j.vaccine.2023.12.074 -
NLM
Fonseca HAR, Zimerman A, Monfardini F, Guimaraes HP, Pedrosa RP, Patriota R de LS, Patriota TLGC, Passos LCS, Dall'orto FTC, Nicolau JC. In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: a prespecified analysis of the VIP-ACS trial [Internet]. Vaccine. 2024 ; 42( 3): 496-504.[citado 2026 mar. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58827 -
Vancouver
Fonseca HAR, Zimerman A, Monfardini F, Guimaraes HP, Pedrosa RP, Patriota R de LS, Patriota TLGC, Passos LCS, Dall'orto FTC, Nicolau JC. In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: a prespecified analysis of the VIP-ACS trial [Internet]. Vaccine. 2024 ; 42( 3): 496-504.[citado 2026 mar. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58827 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
